威海百合生物技術(shù)股份有限公司成立于2005年，先后通過(guò)了美國(guó)NSF工廠認(rèn)證、美國(guó)FDA注冊(cè)、英國(guó)BRCGS認(rèn)證、HACCP認(rèn)證、歐盟水產(chǎn)品注冊(cè)，加拿大FSRN注冊(cè)、社會(huì)責(zé)任Smeta認(rèn)證等國(guó)內(nèi)外知名管理體系認(rèn)證或注冊(cè)?？缮a(chǎn)軟膠囊、硬膠囊、片劑、粉劑、顆粒劑、口服液、滴劑、瓶飲、軟飲等10余種劑型，4000余種營(yíng)養(yǎng)保健食品，現(xiàn)有保健食品文號(hào)六百余個(gè)，產(chǎn)品出口歐美等60余個(gè)國(guó)家和地區(qū)，致力于以優(yōu)質(zhì)產(chǎn)品持續(xù)領(lǐng)跑行業(yè)。

威海百合認(rèn)為，創(chuàng)新產(chǎn)品能夠大大留存用戶，保持優(yōu)良品質(zhì)經(jīng)受得住消費(fèi)者以及時(shí)間的考驗(yàn)。故而威海百合決定從傳統(tǒng)工廠到智能化工廠方向發(fā)展，運(yùn)用產(chǎn)品數(shù)字化、生產(chǎn)數(shù)字化、設(shè)備數(shù)字化、管理數(shù)據(jù)化，實(shí)以實(shí)現(xiàn)“6個(gè)1”數(shù)字化管理目標(biāo)。同時(shí)威海百合還建有CNAS實(shí)驗(yàn)室認(rèn)可標(biāo)準(zhǔn)的檢測(cè)中心，擁有專(zhuān)業(yè)的研發(fā)團(tuán)隊(duì)，同時(shí)與中科院、中國(guó)海洋大學(xué)等多個(gè)知名高校合作，不斷加大研發(fā)投入，根據(jù)消費(fèi)者的需求，對(duì)自身的產(chǎn)品進(jìn)行創(chuàng)新。

如今的威海百合已經(jīng)擁有從研發(fā)、法規(guī)、生產(chǎn)、檢測(cè)、質(zhì)量管理到采購(gòu)、倉(cāng)儲(chǔ)、物流，八大部門(mén)建立的強(qiáng)大供應(yīng)鏈管理，致力打造全球領(lǐng)先的營(yíng)養(yǎng)食品生產(chǎn)加工基地。

Weihai Baihe Biotechnology Co., Ltd. (hereinafter referred to as "Biohigh"), established in November 2005, is one of the leading national high-tech company specializing in the research, development, production and sales of nutrition and health food. Listed on the main board of the Shanghai Stock Exchange in January 2022, stock code: 603102, it is the first stock listed on the main board of the nutrition and health food industry.

Biohigh has a high level of large-scale production capacity in the field of nutrition and health food manufacturing with an international advanced automated production system, which is linked through ERP, MES, WMS, SRM intelligent information systems. Based on that system, the company can conduct in-depth data exchange and interconnection, quickly respond to market demands, and improve delivery rates.

Biohigh owns 2 main GMP factories, covering an area of 300 mu (20 hectares) and 20,000 GMP workshops, with over 1000 employees, which can produce more than 10 dosage forms such as soft capsules, hard capsules, tablets, powders, granules, oral liquids, drops, bottle drinks and soft drinks. The daily production capacity of all products has exceeded 3 million bottles (boxes, bags).

Biohigh has successively received the multiple quality management system certifications and registration of well-known trademarks, such as ISO quality certifications, NSF, US FDA Registration, EU fishery Registration No., BRCGS, HACCP, FSRN, Smeta, etc. The products are exported to more than 70contries all over the world

R&D innovation is the core driving force for Biohigh's rapid development, and the annual R&D investment exceeds 3.6% of sales revenue. It has applied for more than 200 patents successively, and has obtained a number of production qualifications such as health food, general food, supplementary food for pregnant and infants, and sports nutrition. Every year, more than 400 new products are launched, and more than 700 health food approvals are held.

Biohigh has always believed that quality is the foundation for the sustainable development of an enterprise. The company has a testing center that meets the requirements of CNAS standards, more than 120 sets of imported testing equipment, and more than 400 testing items. In terms of process control, the company has continuously improved the quality management system and product traceability system, and established 14 quality control points to strictly control the life quality of each product.

To be a respected enterprise, to be a product of conscience and quality of life -Biohigh is committed to improving and protecting people’s health.